2011-12-13 |
2011-12-12 |
B
Purchase
|
CUBIST PHARMACEUTICALS INC
Large shareholder
|
7,908,727
+100.0%
4.25
USD 33,612,090
|
7,908,727
+100.0%
|
4.25
|
USD 33,612,090
|
|
2011-12-13 |
2011-12-09 |
B
Purchase
|
CUBIST PHARMACEUTICALS INC
Large shareholder
|
45,070,030
+104.1%
4.76
USD 214,533,343
|
45,070,030
+104.1%
|
4.76
|
USD 214,533,343
|
|
2011-12-13 |
2011-12-09 |
B
Purchase
|
CUBIST PHARMACEUTICALS INC
Large shareholder
|
1,729,130
+4.2%
4.25
USD 7,348,803
|
1,729,130
+4.2%
|
4.25
|
USD 7,348,803
|
|
2011-12-09 |
2011-12-08 |
B
Purchase
|
CUBIST PHARMACEUTICALS INC
Large shareholder
|
1,180,983
+2.9%
4.25
USD 5,019,178
|
1,180,983
+2.9%
|
4.25
|
USD 5,019,178
|
|
2011-12-09 |
2011-12-07 |
B
Purchase
|
CUBIST PHARMACEUTICALS INC
Large shareholder
|
4,306,129
+11.9%
4.25
USD 18,301,048
|
4,306,129
+11.9%
|
4.25
|
USD 18,301,048
|
|
2011-12-08 |
2011-12-06 |
B
Purchase
|
MADDEN DAVID
Non-Executive Director
|
18,425
+1.7%
4.66
USD 85,861
|
18,425
+1.7%
|
4.66
|
USD 85,861
|
|
2011-12-08 |
2011-12-06 |
B
Purchase
|
MADDEN DAVID
Non-Executive Director
|
61,650
+6.0%
4.65
USD 286,673
|
61,650
+6.0%
|
4.65
|
USD 286,673
|
|
2011-12-02 |
2011-12-02 |
B
Purchase
|
NICKELSON DONALD E
Non-Executive Director
|
35,000
+11.4%
4.62
USD 161,700
|
35,000
+11.4%
|
4.62
|
USD 161,700
|
|
2011-12-02 |
2011-12-02 |
B
Purchase
|
NICKELSON DONALD E
Non-Executive Director
|
100,000
+48.1%
4.67
USD 467,000
|
100,000
+48.1%
|
4.67
|
USD 467,000
|
|
2011-12-02 |
2011-12-02 |
B
Purchase
|
NICKELSON DONALD E
Non-Executive Director
|
72,896
+53.9%
4.73
USD 344,798
|
72,896
+53.9%
|
4.73
|
USD 344,798
|
|
2011-11-30 |
2011-11-22 |
B
Purchase
|
NICKELSON DONALD E
Non-Executive Director
|
2,643
+2.0%
4.58
USD 12,105
|
2,643
+2.0%
|
4.58
|
USD 12,105
|
|
2011-11-30 |
2011-11-21 |
B
Purchase
|
NICKELSON DONALD E
Non-Executive Director
|
24,461
+22.6%
4.59
USD 112,276
|
24,461
+22.6%
|
4.59
|
USD 112,276
|
|
2011-06-27 |
2011-06-27 |
B
Purchase
|
Webster Stephen W
SVP, Finance & CFO
Officer
|
10,000
+7.8%
1.88
USD 18,800
|
10,000
+7.8%
|
1.88
|
USD 18,800
|
|
2011-06-22 |
2011-06-15 |
B
Purchase
|
Limongelli John M
SVP, General Counsel & Secr.
Officer
|
3,010
+1.6%
1.80
USD 5,418
|
3,010
+1.6%
|
1.80
|
USD 5,418
|
|
2011-06-22 |
2011-06-14 |
B
Purchase
|
Limongelli John M
SVP, General Counsel & Secr.
Officer
|
13,190
+7.6%
1.90
USD 25,061
|
13,190
+7.6%
|
1.90
|
USD 25,061
|
|
2010-12-23 |
2010-12-23 |
B
Purchase
|
DOUGHERTY MICHAEL R
President & CEO
Executive Director
|
30,000
+5.1%
1.18
USD 35,400
|
30,000
+5.1%
|
1.18
|
USD 35,400
|
|
2010-10-29 |
2010-10-29 |
S
Sale
|
Baker Biotech Capital (GP), LLC
Large shareholder
|
376
-0.5%
1.18
USD 445
|
376
-0.5%
|
1.18
|
USD 445
|
|
2010-10-29 |
2010-10-29 |
S
Sale
|
Baker Bros. Capital (GP), LLC
Large shareholder
|
14
-0.5%
1.18
USD 17
|
14
-0.5%
|
1.18
|
USD 17
|
|
2010-10-29 |
2010-10-29 |
S
Sale
|
14159 capital (GP), LLC
Large shareholder
|
884
-0.5%
1.18
USD 1,046
|
884
-0.5%
|
1.18
|
USD 1,046
|
|
2010-10-29 |
2010-10-29 |
S
Sale
|
Baker / Tisch Capital (GP), LLC
Large shareholder
|
60
-0.5%
1.18
USD 71
|
60
-0.5%
|
1.18
|
USD 71
|
|
2010-10-29 |
2010-10-29 |
S
Sale
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
31,666
-0.5%
1.18
USD 37,461
|
31,666
-0.5%
|
1.18
|
USD 37,461
|
|
2010-10-29 |
2010-10-28 |
S
Sale
|
Baker Biotech Capital (GP), LLC
Large shareholder
|
885
-1.1%
1.19
USD 1,052
|
885
-1.1%
|
1.19
|
USD 1,052
|
|
2010-10-29 |
2010-10-28 |
S
Sale
|
Baker Bros. Capital (GP), LLC
Large shareholder
|
33
-1.1%
1.19
USD 39
|
33
-1.1%
|
1.19
|
USD 39
|
|
2010-10-29 |
2010-10-28 |
S
Sale
|
14159 capital (GP), LLC
Large shareholder
|
2,086
-1.1%
1.19
USD 2,479
|
2,086
-1.1%
|
1.19
|
USD 2,479
|
|
2010-10-29 |
2010-10-28 |
S
Sale
|
Baker / Tisch Capital (GP), LLC
Large shareholder
|
142
-1.1%
1.19
USD 169
|
142
-1.1%
|
1.19
|
USD 169
|
|
2010-10-29 |
2010-10-28 |
S
Sale
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
74,670
-1.1%
1.19
USD 88,738
|
74,670
-1.1%
|
1.19
|
USD 88,738
|
|
2010-10-29 |
2010-10-27 |
S
Sale
|
Baker Biotech Capital (GP), LLC
Large shareholder
|
569
-0.7%
1.30
USD 740
|
569
-0.7%
|
1.30
|
USD 740
|
|
2010-10-29 |
2010-10-27 |
S
Sale
|
Baker Bros. Capital (GP), LLC
Large shareholder
|
21
-0.7%
1.30
USD 27
|
21
-0.7%
|
1.30
|
USD 27
|
|
2010-10-29 |
2010-10-27 |
S
Sale
|
14159 capital (GP), LLC
Large shareholder
|
1,341
-0.7%
1.30
USD 1,743
|
1,341
-0.7%
|
1.30
|
USD 1,743
|
|
2010-10-29 |
2010-10-27 |
S
Sale
|
Baker / Tisch Capital (GP), LLC
Large shareholder
|
91
-0.7%
1.30
USD 118
|
91
-0.7%
|
1.30
|
USD 118
|
|
2010-10-29 |
2010-10-27 |
S
Sale
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
47,978
-0.7%
1.30
USD 62,371
|
47,978
-0.7%
|
1.30
|
USD 62,371
|
|
2010-10-29 |
2010-10-27 |
S
Sale
|
Baker Biotech Capital (GP), LLC
Large shareholder
|
233
-0.3%
1.28
USD 298
|
233
-0.3%
|
1.28
|
USD 298
|
|
2010-10-29 |
2010-10-27 |
S
Sale
|
Baker Bros. Capital (GP), LLC
Large shareholder
|
9
-0.3%
1.28
USD 11
|
9
-0.3%
|
1.28
|
USD 11
|
|
2010-10-29 |
2010-10-27 |
S
Sale
|
14159 capital (GP), LLC
Large shareholder
|
550
-0.3%
1.28
USD 702
|
550
-0.3%
|
1.28
|
USD 702
|
|
2010-10-29 |
2010-10-27 |
S
Sale
|
Baker / Tisch Capital (GP), LLC
Large shareholder
|
37
-0.3%
1.28
USD 47
|
37
-0.3%
|
1.28
|
USD 47
|
|
2010-10-29 |
2010-10-27 |
S
Sale
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
19,671
-0.3%
1.28
USD 25,120
|
19,671
-0.3%
|
1.28
|
USD 25,120
|
|
2010-06-02 |
2010-06-01 |
B
Purchase
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
2,238
+0.0%
1.58
USD 3,536
|
2,238
+0.0%
|
1.58
|
USD 3,536
|
|
2010-06-02 |
2010-06-01 |
B
Purchase
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
405,401
+6.3%
1.64
USD 664,736
|
405,401
+6.3%
|
1.64
|
USD 664,736
|
|
2010-06-02 |
2010-06-01 |
B
Purchase
|
14159 capital (GP), LLC
Large shareholder
|
62
+0.0%
1.58
USD 98
|
62
+0.0%
|
1.58
|
USD 98
|
|
2010-06-02 |
2010-06-01 |
B
Purchase
|
14159 capital (GP), LLC
Large shareholder
|
11,190
+6.2%
1.64
USD 18,348
|
11,190
+6.2%
|
1.64
|
USD 18,348
|
|
2010-06-02 |
2010-05-28 |
B
Purchase
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
21,604
+0.3%
1.56
USD 33,750
|
21,604
+0.3%
|
1.56
|
USD 33,750
|
|
2010-06-02 |
2010-05-28 |
B
Purchase
|
14159 capital (GP), LLC
Large shareholder
|
596
+0.3%
1.56
USD 931
|
596
+0.3%
|
1.56
|
USD 931
|
|
2010-06-02 |
2010-05-28 |
B
Purchase
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
517,045
+8.8%
1.60
USD 828,409
|
517,045
+8.8%
|
1.60
|
USD 828,409
|
|
2010-06-02 |
2010-05-28 |
B
Purchase
|
14159 capital (GP), LLC
Large shareholder
|
14,272
+8.6%
1.60
USD 22,867
|
14,272
+8.6%
|
1.60
|
USD 22,867
|
|
2010-05-27 |
2010-05-27 |
B
Purchase
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
44,862
+0.8%
1.60
USD 71,640
|
44,862
+0.8%
|
1.60
|
USD 71,640
|
|
2010-05-27 |
2010-05-27 |
B
Purchase
|
14159 capital (GP), LLC
Large shareholder
|
1,238
+0.8%
1.60
USD 1,977
|
1,238
+0.8%
|
1.60
|
USD 1,977
|
|
2010-05-27 |
2010-05-26 |
B
Purchase
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
64,420
+1.1%
1.59
USD 102,196
|
64,420
+1.1%
|
1.59
|
USD 102,196
|
|
2010-05-27 |
2010-05-26 |
B
Purchase
|
14159 capital (GP), LLC
Large shareholder
|
1,778
+1.1%
1.59
USD 2,821
|
1,778
+1.1%
|
1.59
|
USD 2,821
|
|
2010-05-27 |
2010-05-25 |
B
Purchase
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
68,534
+1.2%
1.60
USD 109,558
|
68,534
+1.2%
|
1.60
|
USD 109,558
|
|
2010-05-27 |
2010-05-25 |
B
Purchase
|
14159 capital (GP), LLC
Large shareholder
|
1,892
+1.2%
1.60
USD 3,025
|
1,892
+1.2%
|
1.60
|
USD 3,025
|
|
2010-05-03 |
2010-04-30 |
B
Purchase
|
14159 capital (GP), LLC
Large shareholder
|
970
+0.6%
1.99
USD 1,928
|
970
+0.6%
|
1.99
|
USD 1,928
|
|
2010-05-03 |
2010-04-30 |
B
Purchase
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
35,130
+0.6%
1.99
USD 69,824
|
35,130
+0.6%
|
1.99
|
USD 69,824
|
|
2010-05-03 |
2010-04-29 |
B
Purchase
|
14159 capital (GP), LLC
Large shareholder
|
124
+0.1%
1.94
USD 240
|
124
+0.1%
|
1.94
|
USD 240
|
|
2010-05-03 |
2010-04-29 |
B
Purchase
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
4,508
+0.1%
1.94
USD 8,740
|
4,508
+0.1%
|
1.94
|
USD 8,740
|
|
2010-04-28 |
2010-04-28 |
B
Purchase
|
14159 capital (GP), LLC
Large shareholder
|
3,094
+2.0%
1.92
USD 5,938
|
3,094
+2.0%
|
1.92
|
USD 5,938
|
|
2010-04-28 |
2010-04-28 |
B
Purchase
|
14159 capital (GP), LLC
Large shareholder
|
962
+0.6%
1.82
USD 1,753
|
962
+0.6%
|
1.82
|
USD 1,753
|
|
2010-04-28 |
2010-04-28 |
B
Purchase
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
112,106
+2.0%
1.92
USD 215,165
|
112,106
+2.0%
|
1.92
|
USD 215,165
|
|
2010-04-28 |
2010-04-28 |
B
Purchase
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
34,838
+0.6%
1.82
USD 63,482
|
34,838
+0.6%
|
1.82
|
USD 63,482
|
|
2010-04-28 |
2010-04-27 |
B
Purchase
|
14159 capital (GP), LLC
Large shareholder
|
98
+0.1%
2.06
USD 202
|
98
+0.1%
|
2.06
|
USD 202
|
|
2010-04-28 |
2010-04-27 |
B
Purchase
|
14159 capital (GP), LLC
Large shareholder
|
217
+0.1%
2.08
USD 451
|
217
+0.1%
|
2.08
|
USD 451
|
|
2010-04-28 |
2010-04-27 |
B
Purchase
|
14159 capital (GP), LLC
Large shareholder
|
609
+0.4%
2.08
USD 1,267
|
609
+0.4%
|
2.08
|
USD 1,267
|
|
2010-04-28 |
2010-04-27 |
B
Purchase
|
14159 capital (GP), LLC
Large shareholder
|
489
+0.3%
2.08
USD 1,016
|
489
+0.3%
|
2.08
|
USD 1,016
|
|
2010-04-28 |
2010-04-27 |
B
Purchase
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
3,550
+0.1%
2.06
USD 7,313
|
3,550
+0.1%
|
2.06
|
USD 7,313
|
|
2010-04-28 |
2010-04-27 |
B
Purchase
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
7,858
+0.1%
2.08
USD 16,342
|
7,858
+0.1%
|
2.08
|
USD 16,342
|
|
2010-04-28 |
2010-04-27 |
B
Purchase
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
22,055
+0.4%
2.08
USD 45,894
|
22,055
+0.4%
|
2.08
|
USD 45,894
|
|
2010-04-28 |
2010-04-27 |
B
Purchase
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
17,709
+0.3%
2.08
USD 36,790
|
17,709
+0.3%
|
2.08
|
USD 36,790
|
|
2010-04-28 |
2010-04-26 |
B
Purchase
|
14159 capital (GP), LLC
Large shareholder
|
1,222
+0.8%
2.05
USD 2,509
|
1,222
+0.8%
|
2.05
|
USD 2,509
|
|
2010-04-28 |
2010-04-26 |
B
Purchase
|
14159 capital (GP), LLC
Large shareholder
|
11
+0.0%
2.06
USD 23
|
11
+0.0%
|
2.06
|
USD 23
|
|
2010-04-28 |
2010-04-26 |
B
Purchase
|
14159 capital (GP), LLC
Large shareholder
|
1,393
+0.9%
2.07
USD 2,885
|
1,393
+0.9%
|
2.07
|
USD 2,885
|
|
2010-04-28 |
2010-04-26 |
B
Purchase
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
44,258
+0.8%
2.05
USD 90,862
|
44,258
+0.8%
|
2.05
|
USD 90,862
|
|
2010-04-28 |
2010-04-26 |
B
Purchase
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
389
+0.0%
2.06
USD 801
|
389
+0.0%
|
2.06
|
USD 801
|
|
2010-04-28 |
2010-04-26 |
B
Purchase
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
50,451
+0.9%
2.07
USD 104,489
|
50,451
+0.9%
|
2.07
|
USD 104,489
|
|
2010-04-28 |
2010-04-26 |
B
Purchase
|
14159 capital (GP), LLC
Large shareholder
|
159
+0.1%
2.06
USD 328
|
159
+0.1%
|
2.06
|
USD 328
|
|
2010-04-28 |
2010-04-26 |
B
Purchase
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
5,755
+0.1%
2.06
USD 11,855
|
5,755
+0.1%
|
2.06
|
USD 11,855
|
|
2009-09-24 |
2009-09-22 |
S
Sale
|
BVF PARTNERS L P/IL
Direct Beneficial Owner
Large shareholder
|
166,000
-3.9%
1.69
USD 280,972
|
166,000
-3.9%
|
1.69
|
USD 280,972
|
|